Statement re EGM and authority to issue shares

RNS Number : 3866O
Martin Currie Global Portfolio Tst
09 February 2021
 

Martin Currie Global Portfolio Trust PLC

Legal Entity Identifier: 549300RKB85NFVSTBM94

 

Proposals for further share issuance

February 9, 2021

 

 

The Board of Martin Currie Global Portfolio Trust PLC (the "Company") today announces that, in light of the continuing demand for the Company's shares, it will shortly publish a circular to seek approval from its shareholders to disapply pre-emption rights in relation to the issue of shares pursuant to the Company's general authority to issue shares.

 

At the Company's Annual General Meeting held on 23 July 2020, shareholders granted the Directors authority to issue 4,190,260 new shares on a non-pre-emptive basis, being approximately 5% of the shares in issue at that date. Since then, demand for the Company's shares has been such that 4,055,000 of these shares have been issued as at the date of this announcement. The Board believes that the existing authority may be exhausted in the near future and therefore, in order to meet potential continuing demand for new share issuances from investors, the Board intends to seek shareholder approval for the authority to issue further shares to meet market demand at an Extraordinary General Meeting (EGM). New shares will only be issued at a price above the prevailing net asset value per share at the time of issue and when the Directors believe that issuing shares is in the best interests of existing shareholders.

 

Details of the EGM will be published shortly.

 

For further information, please contact:

 

Ewan Cameron

For and on behalf of

Martin Currie Investment Management Limited

Company Secretary

0131 229 5252

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDBGDDXUGDGBI
UK 100

Latest directors dealings